In the pioneering work by Steidler et al., genetically modified Lactococcus (Lc.) lactis, expressing murine IL-10, was able to prevent colitis development in IL-10 KO mice and to improve inflammation in DSS-induced colitis [25]. This evidence concerns the gene IL10 and colitis.